About Timothy Scannell
Timothy Scannell is a director at Masimo.
Form D filings name Timothy Scannell as a director at Molekule Group.
Timothy Scannell reports to the SEC as a director or officer of 7 public companies, including NovoCure (NVCR), Insulet (PODD) and Exact Sciences (EXAS).
Timothy Scannell first appears on SEC filings in 2008.
Experience
This experience comes from SEC filings. The years are when the filings name Timothy Scannell in the role, so the role may have started earlier or lasted longer.
MC
Masimo Corp.
Director
2024 – 2026 · Public company (MASI)
NL
NovoCure Ltd
Director
2021 – 2026 · Public company (NVCR)
IC
Insulet Corp.
Director
2014 – 2026 · Public company (PODD)
EC
Exact Sciences Corp.
Director
2023 · Public company (EXAS)
RP
Renalytix plc
Director
2023 · Public company (RNLX)
SC
Stryker Corp.
President and COO
2008 – 2021 · Public company (SYK)
Key Colleagues at Startups
The people Timothy Scannell works with at each company, as listed on that company's latest Form D.
Molekule Group, Inc. · Form D, Jun 16, 2025
TM
Thomas McCaffrey
Director
AK
Amin Khoury
Director
JD
Jason DiBona
Executive officer
SW
Stephen Ward
Director
MS
Michael Senft
Director
BF
Brad Feld
Director
RP
Ryan Patch
Senior Vice President and Corporate Secretary
DH
David Helfet
Director